15 May 2023

CANADA – Juno Pharmaceuticals Canada completes acquisition of Omega Laboratories

Juno Pharmaceutical Limited Canada (“Juno Canada”), a portfolio company of Juno Pharmaceuticals LP (“Juno LP”), has completed the acquisition of Omega Laboratories (“Omega”).

Omega is one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers. With the acquisition, Juno Canada will benefit from Omega’s newly opened injectable manufacturing facility, which has received Health Canada and the US Food and Drug Administration GMP certification.

Bloom Burton Securities Inc. served as financial advisor, while Aird & Berlis LLP acted as legal counsel to the acquisition. Read More